Artwork

Content provided by Noah Goodson, PhD and Noah Goodson. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Noah Goodson, PhD and Noah Goodson or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

Bluebird, Endo & Pharmacies, Genentech + Jemincare, Merck + Orna

8:33
 
Share
 

Manage episode 338714477 series 2833924
Content provided by Noah Goodson, PhD and Noah Goodson. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Noah Goodson, PhD and Noah Goodson or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

Gene therapy approval, opioid costs continue, a $650M deal, and a $3.5B RNA partnership.
Find out more at
https://LifeScienceTodayPodcast.com

Story References
Bluebird
Endo & Pharmacies
Genentech + Jemincare
Merck + Orna

About the Show
Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech IPOs. Life Science Today also explores trends around clinical research, including the evolving patterns that determine how drugs and therapies are developed and approved. It’s news, with a dash of perspective, focused on the life science industry.

  continue reading

72 episodes

Artwork
iconShare
 
Manage episode 338714477 series 2833924
Content provided by Noah Goodson, PhD and Noah Goodson. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Noah Goodson, PhD and Noah Goodson or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

Gene therapy approval, opioid costs continue, a $650M deal, and a $3.5B RNA partnership.
Find out more at
https://LifeScienceTodayPodcast.com

Story References
Bluebird
Endo & Pharmacies
Genentech + Jemincare
Merck + Orna

About the Show
Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech IPOs. Life Science Today also explores trends around clinical research, including the evolving patterns that determine how drugs and therapies are developed and approved. It’s news, with a dash of perspective, focused on the life science industry.

  continue reading

72 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide